Testing SABR Radiation for Advanced Breast Cancer
Part of Cancer, Skin clinical trials.
This trial tests a precise type of radiation (SABR) for breast cancer that has spread to other parts of the body. It aims to see if adding SABR to your regular systemic therapy can help control the tumor in the breast and improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer that has spread to other parts of the body (Stage IV).
- You have a tumor in the breast that can be treated with a high-precision radiation called SABR.
- You are currently receiving or will receive systemic therapy (such as chemotherapy or hormone therapy).
- You are at least 18 years old.
- Your health is good enough to carry out daily activities (ECOG score 0-2).
- You have not had radiation to the same breast before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise, high-dose radiation treatment (called SABR) for older women with early-stage breast cancer who choose not to have surgery. It aims to control the tumor with fewer side effects and may be an option if you have a small, ER+, HER2- tumor that hasn't spread to lymph nodes.
This trial tests whether adding focused, high-dose radiation (SABR) to standard drug therapy can better control cancer that has spread to a few spots in the body. It is for people starting or resuming cancer medicines for newly found or growing metastases.
This trial tests whether a precise form of high-dose radiation can control up to 1–5 breast cancer metastases (spread) in a few body areas. It may help by focusing treatment only on visible spots while limiting radiation to the rest of the body.
This trial tests a precise, high-dose radiation technique (SABR) for people whose cancer has started to grow again in only a few spots despite ongoing medication. The goal is to control those new growths while continuing your current treatment.
This trial tests whether adding a precise, high-dose radiation (called SABR) to your current targeted therapy can control a few growing spots of advanced breast cancer better than switching to a different drug. It is for people with ER-positive, HER2-negative breast cancer whose cancer has been well controlled for at least 6 months but now has 1–5 spots that are starting to grow.
This study tests a precise radiation technique called SABR to treat cancer that has spread to a few spots. It aims to see if this approach can help control the cancer better than usual treatment, especially for lung, prostate, colorectal, or other solid tumors with limited spread.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.